Donanemab’s approval around the world: How long will you have to wait?
Donanemab: the new Alzheimer’s medicine that brings hope Similar to the previously approved Leqembi (lecanemab) and Aduhelm (aducanumab), also Kisunla (donanemab) works by targeting amyloid plaques in the brain. The…
Read more